Withdrawal of pholcodine-containing cough medicines: the what, when and where to now?

An in-depth look at pholcodine, and why it was taken off the market. By Denise Hope, Dr Matt Zunk and Dr Santosh Rudrawar While the recent cancellation of the cough suppressant pholcodine from the Australian Register of Therapeutic Goods (ARTG) [1] might have surprised consumers and the Australian public, it is not surprising to health

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous ‘We cannot keep doing more with less’
Next Dispensing fees not for cross-subsidising services: Shakespeare